Work

Pembrolizumab (MK-3475) in patients (pts) with extensive-stage small cell lung cancer (SCLC): Preliminary safety and efficacy results from KEYNOTE-028.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.7502

Authors: Patrick Alexander Ott, Maria Elena Elez Fernandez, Sandrine Hiret, Dong-Wan Kim, Rebecca Anne Moss, Tammy Winser, Sammy Yuan, Jonathan D. Cheng, Bilal Piperdi, Janice M. Mehnert

Institutions: Dana-Farber Cancer Institute, Vall d'Hebron Hospital Universitari, Seoul National University Hospital, Rutgers Cancer Institute, Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2263979489

Cites:

Cited by: 86

Related to: 10